Comparison

Ertugliflozin L-pyroglutamic acid European Partner

Item no. TMO-T15244-50mg
Manufacturer TargetMol
CASRN 1210344-83-4
Amount 50mg
Category
Type Molecules
Format Powder
Specific against other
Purity 0,98
Smiles CCOc1ccc(Cc(cc([C@]([C@@H]([C@H]2O)O)(OC3)O[C@]3(CO)[C@H]2O)cc2)c2Cl)cc1.OC([C@H](CC1)NC1=O)=O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 1210344-83-4, PF-04971729 L-pyroglutamic acid
Available
Short Description
Ertugliflozin L-pyroglutamic acid is a selective and orally active hSGLT2 inhibitor with an IC50 of 0.877 nM. Ertugliflozin L-pyroglutamic acid can be used for studies about the treatment of type 2 diabetes mellitus.
Shipping
cool pack
Storage
-20°
Target names or alias
PF-04971729 L-pyroglutamic acid
Molecular Weight
566
Pathway
GPCR/G Protein|||Others
Target
SGLT|||Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?